EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Beta‐lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study

Ilja Areskog Lejbman iD, Gustav Torisson, Fredrik Resman, Fredrik Sjövall iD

Acta Anaesthesiologica Scandinavica · 2024

DOI: 10.1111/aas.14382 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2024. Verfasst von Ilja Areskog Lejbman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Piperacillin, Critical Illness. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council Grant, Skane Region Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antibiotic concentration target attainment is known to be poor in critically ill patients. Dose adjustment is recommended in patients with altered clearance, obesity and those with bacterial species with intermediate susceptibility. The aim of this study was to investigate the variation of antibiotic concentration in critically ill patients with standard or adjusted dosing regimens.

Methods

The concentration of three beta‐lactam antibiotics used in the intensive care unit (ICU) setting, cefotaxime, piperacillin/tazobactam, and meropenem, was measured in patients with confirmed or suspected infection. Mid‐dose and trough values were collected during a single dosing interval. The pharmacokinetic endpoints were a free antibiotic concentration that, during the whole dosing interval, was above MIC (100% ƒT > MIC, primary endpoint) or above four times MIC (100% ƒT > 4MIC, secondary endpoint). Non‐species related MIC breakpoints were used (1 mg/L for cefotaxime, 8 mg/L for piperacillin/tazobactam, and 2 mg/L for meropenem).

Results

We included 102 patients (38 cefotaxime, 30 piperacillin/tazobactam, and 34 meropenem) at a single ICU, with a median age of 66 years. In total, 73% were males, 40% were obese (BMI ≥30) and the median SAPS 3 score was 63 points. Of all patients, 78 patients (76%) reached the primary endpoint (100%ƒT > MIC), with 74% for cefotaxime, 67% for piperacillin/tazobactam and 88% for meropenem. Target attainment for 100% ƒT > 4MIC was achieved in 40 (39%) patients, overall, with 34% for cefotaxime, 30% for piperacillin/tazobactam and 53% for meropenem. In patients with standard dose 71% attained 100%ƒT > MIC and 37% for 100%ƒT > 4MIC. All patients with reduced dose attained 100%ƒT > MIC and 27% attained 100% ƒT > 4MIC. In patients with increased dose 79% attained 100%ƒT > MIC and 48% 100%ƒT > 4MIC respectively.

Conclusions

Beta‐lactam antibiotics concentration vary widely in critically ill patients. The current standard dosing regimens employed during the study were not sufficient to reach 100% ƒT > MIC in approximately a quarter of the patients. In patients where dose adjustment was performed, the group with increased dose also had low target attainment, as opposed to patients with dose reduction, who all reached target. This suggests the need for further individualization of dosing where therapeutic drug monitoring can be an alternative to further increase target attainment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperacillinCritical IllnessMaleHumansAgedFemaleMeropenemAnti-Bacterial AgentsPiperacillin, Tazobactam Drug CombinationMonobactamsCefotaximebeta Lactam Antibiotics

Stichwörter der Autor:innen

Antibioticsantibiotic concentrationbeta-lactamcritically ill patientsdosageintensive care unittherapeutic drug monitoring

Substanzen

MeropenemPiperacillinAnti-Bacterial AgentsPiperacillin, Tazobactam Drug CombinationMonobactamsCefotaximebeta Lactam Antibiotics

Autor:innen und Institutionen

  • Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden.
  • Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden.
  • Department of Clinical Sciences, Lund University, Lund, Sweden.

ORCID-Profile: Ilja Areskog Lejbman, Fredrik Sjövall

Förderung

  • Swedish Research Council Grant
  • Skane Region Research Funds

Zitieren

APA

Areskog Lejbman, I., Torisson, G., Resman, F., & Sjövall, F. (2024). Beta‐lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14382

Vancouver

Areskog Lejbman I, Torisson G, Resman F, Sjövall F. Beta‐lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study. Acta Anaesthesiologica Scandinavica. 2024. doi:10.1111/aas.14382

BibTeX
@article{AreskogLejbman2024,
  author = {Areskog Lejbman, Ilja and Torisson, Gustav and Resman, Fredrik and Sjövall, Fredrik},
  title = {Beta‐lactam antibiotic concentrations in critically ill patients with standard and adjusted dosages: A prospective observational study},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2024},
  doi = {10.1111/aas.14382}
}
Kostenlos starten →